These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 16567265

  • 1. New therapies for uremic secondary hyperparathyroidism.
    Torres PU, Prié D, Beck L, Friedlander G.
    J Ren Nutr; 2006 Apr; 16(2):87-99. PubMed ID: 16567265
    [Abstract] [Full Text] [Related]

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 3. Pathophysiology of calcium and phosphate metabolism impairment in chronic kidney disease.
    Cozzolino M, Ciceri P, Volpi EM, Olivi L, Messa PG.
    Blood Purif; 2009 Nov; 27(4):338-44. PubMed ID: 19295196
    [Abstract] [Full Text] [Related]

  • 4. Secondary hyperparathyroidism: pathogenesis, disease progression, and therapeutic options.
    Cunningham J, Locatelli F, Rodriguez M.
    Clin J Am Soc Nephrol; 2011 Apr; 6(4):913-21. PubMed ID: 21454719
    [Abstract] [Full Text] [Related]

  • 5. Emerging role for the vitamin D receptor activator (VDRA), paricalcitol, in the treatment of secondary hyperparathyroidism.
    Cozzolino M, Brancaccio D.
    Expert Opin Pharmacother; 2008 Apr; 9(6):947-54. PubMed ID: 18377338
    [Abstract] [Full Text] [Related]

  • 6. Therapeutic strategies for secondary hyperparathyroidism in dialysis patients.
    Ogata H, Koiwa F, Ito H, Kinugasa E.
    Ther Apher Dial; 2006 Aug; 10(4):355-63. PubMed ID: 16911189
    [Abstract] [Full Text] [Related]

  • 7. [Pathogenesis of secondary hyperparathyroidism and renal bone disease].
    Ito H, Kinugasa E.
    Clin Calcium; 2004 May; 14(5):720-5. PubMed ID: 15577032
    [Abstract] [Full Text] [Related]

  • 8. Effectiveness of surgical parathyroidectomy for secondary hyperparathyroidism in renal dialysis patients in Qatar.
    Rashed A, Fahmi M, ElSayed M, Aboud O, Asim M.
    Transplant Proc; 2004 May; 36(6):1815-7. PubMed ID: 15350484
    [Abstract] [Full Text] [Related]

  • 9. Management of secondary hyperparathyroidism.
    Cunningham J.
    Ther Apher Dial; 2005 Aug; 9 Suppl 1():S35-40. PubMed ID: 16109140
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Hypoparathyroidism associated with severe mineral bone disease postrenal transplantation, treated successfully with recombinant PTH.
    Mahajan A, Narayanan M, Jaffers G, Concepcion L.
    Hemodial Int; 2009 Oct; 13(4):547-50. PubMed ID: 19493022
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Parathyroid growth and suppression in renal failure.
    Lewin E, Huan J, Olgaard K.
    Semin Dial; 2006 Oct; 19(3):238-45. PubMed ID: 16689976
    [Abstract] [Full Text] [Related]

  • 16. Long-term outcome after total parathyroidectomy for the management of secondary hyperparathyroidism.
    Stracke S, Keller F, Steinbach G, Henne-Bruns D, Wuerl P.
    Nephron Clin Pract; 2009 Oct; 111(2):c102-9. PubMed ID: 19142022
    [Abstract] [Full Text] [Related]

  • 17. Management of secondary hyperparathyroidism in uremic patients: the role of the new vitamin D analogs.
    Brancaccio D, Cozzolino M, Galassi A, Chiarelli G, Butti A, Bellasi A, Rocca-Rey L, Volpi A, Anelli A, Zoni U, Fusaro M, Brambilla C, Missaglia E, Crovetto C, Russo M, Longhini C, Provenzano R, Incalcaterra F, Cerasola G, Li Vecchi M, Gallieni M.
    J Nephrol; 2007 Oct; 20(1):3-9. PubMed ID: 17347966
    [Abstract] [Full Text] [Related]

  • 18. Drug insight: vitamin D analogs in the treatment of secondary hyperparathyroidism in patients with chronic kidney disease.
    Brown AJ, Slatopolsky E.
    Nat Clin Pract Endocrinol Metab; 2007 Feb; 3(2):134-44. PubMed ID: 17237840
    [Abstract] [Full Text] [Related]

  • 19. [What are the actual indications for a surgical parathiroidectomy?].
    Torres PU.
    Nephrol Ther; 2005 Dec; 1 Suppl 4():S342-50. PubMed ID: 17373206
    [Abstract] [Full Text] [Related]

  • 20. Pathogenesis of parathyroid hyperplasia in renal failure.
    Cozzolino M, Brancaccio D, Gallieni M, Galassi A, Slatopolsky E, Dusso A.
    J Nephrol; 2005 Dec; 18(1):5-8. PubMed ID: 15772917
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.